Login / Signup

Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.

Janis FrickeAlexander SherwoodRobert KargboAndrew OrryFelix BleiAndreas NaschbergerBernhard RuppDirk Hoffmeister
Published in: Chembiochem : a European journal of chemical biology (2019)
Psilocybin and its direct precursor baeocystin are indole alkaloids of psychotropic Psilocybe mushrooms. The pharmaceutical interest in psilocybin as a treatment option against depression and anxiety is currently being investigated in advanced clinical trials. Here, we report a biocatalytic route to synthesize 6-methylated psilocybin and baeocystin from 4-hydroxy-6-methyl-l-tryptophan, which was decarboxylated and phosphorylated by the Psilocybe cubensis biosynthesis enzymes PsiD and PsiK. N-Methylation was catalyzed by PsiM. We further present an in silico structural model of PsiM that revealed a well-conserved SAM-binding core along with peripheral nonconserved elements that likely govern substrate preferences.
Keyphrases
  • clinical trial
  • transcription factor
  • hydrogen peroxide
  • molecular docking
  • room temperature
  • genome wide
  • gene expression
  • single cell
  • dna binding
  • open label
  • molecular dynamics simulations
  • phase iii